Indications : התוויות

Therapeutic Indications                                                                                          system (particularly CYP 3A4 or CYP 2D6). Inhibition of these routes of metabolism by another drug or a                                                                                                                                    chemoreceptor-trigger zone), the relaxation of the gastro-intestinal sphincters and the increased prolactin release Psychiatric Disorders: Libido decreased; Loss of libido; Restlessness
PERICATE is indicated for the maintenance therapy of chronic schizophrenic patients.                                  decrease in CYP 2D6 enzyme activity may result in increased haloperidol concentrations and an increased                                                                                                                                    (through an inhibition of the activity of the prolactin inhibiting factor, PIF, at the level of the adenohypophysis). Nervous System Disorders: Neuroleptic malignant syndrome; Tardive dyskinesia; Bradykinesia; Dizziness;
risk of adverse events, including QT-prolongation. In pharmacokinetic studies, mild to moderately increased
Hyperkinesia; Hypokinesia; Motor dysfunction; Muscle contractions involuntary; Nystagmus